Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Non Operating Interest Expenses (2023)

Pasithea Therapeutics' (KTTAW) quarterly Non Operating Interest Expenses came in at -$117191.0 in Q2 2023, down 1934.55% quarter-over-quarter from $6388.0 in Q1 2023.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Pasithea Therapeutics Corp. (KTTAW) Non Operating Interest Expenses (2023) Analysis & Trends

Pasithea Therapeutics has disclosed Non Operating Interest Expenses across 1 years of filings, most recently posting -$117191.0 for Q2 2023.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -117,191.00
Mar 31, 2023 6,388.00